Evidence map›Paper›PMID 32725221›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

The Surveillance for Enteric Fever in Asia Project (SEAP), Severe Typhoid Fever Surveillance in Africa (SETA), Surveillance of Enteric Fever in India (SEFI), and Strategic Typhoid Alliance Across Africa and Asia (STRATAA) Population-based Enteric Fever Studies: A Review of Methodological Similarities and Differences.

Megan E Carey, William R MacWright, Justin Im, James E Meiring, Malick M Gibani, Se Eun Park, Ashley Longley, Hyon Jin Jeon, Caitlin Hemlock, Alexander T Yu and 29 more

Abstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Typhoid Fever in the Eastern Mediterranean Region: A Systematic Review, 1990-2021.The American journal of tropical medicine and hygiene · 2023
    Pooled it
  3. Trial
  4. Review
  5. Environmental health insights · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Longevity of immune response after a single dose of typhoid conjugate vaccine against Salmonella Typhi among children in Hyderabad, Pakistan.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024
    Article
  12. Exploring the Antimicrobial Resistance Profile ofAntibiotics (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors.

Megan E CareyDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
William R MacWrightPublic Health Surveillance Group, Princeton, New Jersey, USA.
Justin ImInternational Vaccine Institute, SNU Research Park, Seoul, Republic of Korea.
James E MeiringOxford Vaccine Group, University of Oxford, Oxford, United Kingdom.
Malick M GibaniMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Se Eun ParkInternational Vaccine Institute, SNU Research Park, Seoul, Republic of Korea.
Ashley LongleyGlobal Immunization Division, Centers for Disease Control Foundation, Atlanta, Georgia, USA.
Hyon Jin JeonDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Caitlin HemlockDivision of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, California, USA.
Alexander T YuDivision of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, California, USA.
Abdramane SouraInstitut Supérieur des Sciences de la Population, University of Ouagadougou, Ouagadougou, Burkina Faso.
Kristen AiemjoyDivision of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, California, USA.
Ellis Owusu-DaboSchool of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Mekonnen TerferiArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Sahidul IslamChild Health Research Foundation, Department of Microbiology, Dhaka Shishu Hospital, Dhaka, Bangladesh.
Octavie LunguyaDepartment of Microbiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.
Jan JacobsDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Melita GordonMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Christiane DolecekCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Stephen BakerDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Virginia E PitzerDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, Connecticut, USA.
Mohammad Tahir YousafzaiDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Susan TonksOxford Vaccine Group, University of Oxford, Oxford, United Kingdom.
John D ClemensInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Kashmira DateGlobal Immunization Division, Centers for Disease Control Foundation, Atlanta, Georgia, USA.
Firdausi QadriInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Robert S HeydermanDivision of Infection and Immunity, University College London, London, United Kingdom.
Samir K SahaChild Health Research Foundation, Department of Microbiology, Dhaka Shishu Hospital, Dhaka, Bangladesh.
Buddha BasnyatCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Iruka N OkekeDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Idaban, Nigeria.
Farah N QamarDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Merryn VoyseyOxford Vaccine Group, University of Oxford, Oxford, United Kingdom.
Stephen LubyDivision of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, California, USA.
Gagandeep KangChristian Medical College, Vellore, India.
Jason AndrewsDivision of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, California, USA.
Andrew J PollardOxford Vaccine Group, University of Oxford, Oxford, United Kingdom.
Jacob JohnChristian Medical College, Vellore, India.
Denise GarrettSabin Vaccine Institute, Washington, District of Columbia, USA.
Florian MarksDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Building on previous multicountry surveillance studies of typhoid and others salmonelloses such as the Diseases of the Most Impoverished program and the Typhoid Surveillance in Africa Project, several ongoing blood culture surveillance studies are generating important data about incidence, severity, transmission, and clinical features of invasive Salmonella infections in sub-Saharan Africa and South Asia. These studies are also characterizing drug resistance patterns in their respective study sites. Each study answers a different set of research questions and employs slightly different methodologies, and the geographies under surveillance differ in size, population density, physician practices, access to healthcare facilities, and access to microbiologically safe water and improved sanitation. These differences in part reflect the heterogeneity of the epidemiology of invasive salmonellosis globally, and thus enable generation of data that are useful to policymakers in decision-making for the introduction of typhoid conjugate vaccines (TCVs). Moreover, each study is evaluating the large-scale deployment of TCVs, and may ultimately be used to assess post-introduction vaccine impact. The data generated by these studies will also be used to refine global disease burden estimates. It is important to ensure that lessons learned from these studies not only inform vaccination policy, but also are incorporated into sustainable, low-cost, integrated vaccine-preventable disease surveillance systems.

Indexed as

Typhoid FeverTyphoid-Paratyphoid VaccinesAfrica South of the SaharaAsiaHumansIndiaSalmonella typhiTyphoid-Paratyphoid Vaccinesblood cultureenteric fever surveillanceSalmonella Typhityphoid fever

Identifiers

PMID32725221
PMCPMC7388711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.